KBC Group NV/ BE0003565737 /
2024-04-24 5:35:15 PM | Chg. +0.16 | Volume | Bid5:35:15 PM | Ask5:35:15 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
71.36EUR | +0.22% | 192,011 Turnover: 5.81 mill. |
-Bid Size: - | -Ask Size: - | 29.79 bill.EUR | 5.81% | 8.88 |
GlobeNewswire
7:30 AM
ONWARD® Medical Reports Full Year 2023 Financial and Operating Results and Shares 2024 Highlights Ye...
GlobeNewswire
03-21
ONWARD® Medical Successfully Raises €20 Million in a Capital Increase by Way of an Accelerated Bookb...
GlobeNewswire
03-20
ONWARD® Medical Launches Capital Increase by Way of an Accelerated Bookbuild Offering and of a Publi...
GlobeNewswire
03-13
TruEra Launches LLM Evaluation and Observability that Combines Leading Open Source Software and Mass...
GlobeNewswire
03-12
MICLEDI Microdisplays Raises Series A Funding to Advance Best-in-Class microLED Display Design and M...
GlobeNewswire
02-09
KBC Securities Initiates Research Coverage of ONWARD® Medical with a Buy Rating and Target Price of ...
GlobeNewswire
2023-12-01
Energy Capital Vietnam Signs Six Memoranda of Understanding During the Asia-Pacific Cooperation Lead...
Newsfile Corp
2022-10-18
Danavation Technologies Provides Corporate Update Including Three New Contracts for Digital Smart La...
Newsfile Corp
2022-09-19
Danavation Technologies Confirms Installation of Digital Smart Labels(TM) into Kemptville Building C...
GlobeNewswire
2022-03-08
SEQUANA MEDICAL SUCCESSFULLY RAISES EUR 28.4 MILLION IN AN EQUITY PLACEMENT
euro adhoc
2021-11-15
EANS-Adhoc: Raiffeisen Bank International AG / RBI has reached an agreement on the sale of Raiffeise...
GlobeNewswire
2021-09-01
iTeos Therapeutics to Participate in Upcoming September Investor Conferences
GlobeNewswire
2021-02-09
SEQUANA MEDICAL SUCCESSFULLY RAISES EUR 22.5 MILLION IN AN EQUITY PLACEMENT
GlobeNewswire
2020-06-26
Hyloris Pharmaceuticals Raises approximately EUR 61.81 million in Successful Initial Public Offering
GlobeNewswire
2020-06-24
Hyloris Pharmaceuticals Announces Narrowing of Price Range of its Initial Public Offering